ARCHIVES

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

This article is from The Cancer Letter archive.

Vol. 30 No. 9 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

As Avastin Decision Nears, Patient Groups Split On PFS In Front Line Breast Cancer.

February 22, 2008

NCI Awards $6.7 Million For Breast Cancer Research.

September 8, 2000

NCI Breast Tissue Registry Available To Researchers

March 24, 1995

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

September 13, 2002

DCPTC Proceeding With Plans For Intramural Lab

January 30, 1987

Prevention, Centers To Gain, some $$ In President’s Budget

February 8, 1991